STOCK TITAN
  1. Home
  2. News
  3. AFYA

Afya Ltd - AFYA STOCK NEWS

Welcome to our dedicated news page for Afya (Ticker: AFYA), a resource for investors and traders seeking the latest updates and insights on Afya.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Afya's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Afya's position in the market.

News
Afya Limited Announces Fourth Quarter and Full-Year 2023 Financial Results
Rhea-AI Summary
Afya reported strong financial and operating results for the fourth quarter and full-year period ended December 31, 2023. Highlights include a 22.6% increase in 4Q23 Adjusted Net Revenue to R$729.5 million, 19.3% growth in Adjusted EBITDA to R$288.9 million, and a 27.7% rise in Adjusted Net Income to R$164.4 million. For FY23, Adjusted Net Revenue increased by 23.9% to R$2,874.1 million, and Adjusted EBITDA grew by 21.2% to R$1,165.7 million. Cash conversion was at 97.1%, generating R$1,088.8 million in cash flow from operating activities. Afya's Digital Service saw an increase of 2.8% in monthly active physicians and medical students. The company also achieved its 2023 guidance and set new targets for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.41%
Tags
earnings
-
News
Afya Limited Announces Medical Seats Increase in FIP Guanambi
Rhea-AI Summary
Afya Limited, a leading medical education group in Brazil, has received authorization to increase medical seats at FIP Guanambi, resulting in an additional payment of R$49.6 million. This brings Afya's total approved seats to 3,203.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.88%
Tags
none
-
News
Afya Limited Announces Third Quarter and Nine Months 2023 Financial Results
Rhea-AI Summary
Afya Limited (AFYA) Reports Strong Financial Results for Q3 2023, Showing 24.6% YoY Increase in Adjusted Net Revenue and 21.7% YoY Increase in Adjusted EBITDA. Cash Conversion of 109.3% Resulting in R$822.0 Million Solid Cash Position. Over 285 Thousand Monthly Active Physicians and Medical Students Using Afya’s Digital Service.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.39%
Tags
earnings
News
Afya Limited Announces Additional Purchase of 15% of Centro de Ciências em Saúde de Itajubá S.A.
Rhea-AI Summary
Afya Limited, the leading medical education group in Brazil, has announced the acquisition of an additional 15% of Centro de Ciências em Saúde de Itajubá S.A. (CCSI; FMIT), bringing their ownership to 75% of the total share capital. The purchase price for the additional 15% was R$21.0 million, paid in cash. FMIT is a post-secondary education institution offering on-campus undergraduate courses in medicine, with 87 approved medical seats.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.48%
Tags
none
-
News
Afya Limited to Report Third Quarter and Nine Months 2023 Financial Results on November 13th
Rhea-AI Summary
Afya Limited will report third-quarter and nine months 2023 financial results on November 13th, 2023, after the market closes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.78%
Tags
conferences earnings
-
News
Afya Limited Announces Second-Quarter and First-Half 2023 Financial Results
Rhea-AI Summary
Afya Limited reports strong financial results for Q2 2023, with Adjusted Net Revenue increasing 23.6% YoY to R$712.2 million and Adjusted EBITDA increasing 21.8% YoY to R$268.2 million. Cash conversion of 98.9% generated R$566.5 million of cash flow from operating activities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.07%
Tags
earnings
News
Afya Limited to Report Second Quarter and First Half 2023 Financial Results on August 28
Rhea-AI Summary
Afya Limited will report its second-quarter and first half 2023 financial results on August 28, 2023. A conference call and webcast will be held at 05:00 pm EDT.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.89%
Tags
conferences earnings
-
News
Afya Announces the Start of Negotiation of Its Non-Sponsored Brazilian Depositary Receipts (BDRs) in B3
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.77%
Tags
none
-
News
Afya Limited to Host Virtual Investors & ESG Day on July 6th, 2023
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
conferences
News
Afya Limited Announces Results of Annual General Meeting Held on June 15, 2023
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.22%
Tags
none
Stock AFYA logo
Afya Ltd

Nasdaq:AFYA

AFYA Rankings

#2105 Ranked by Market Cap
#1351 Ranked by Stock Gains
N/A Ranked by Dividends

AFYA Stock Data

1.52B
14.91M
55.49%
24.9%
0.97%
Elementary and Secondary Schools
Educational Services
Link
Brazil
Nova Lima

About AFYA

afya limited, through its subsidiaries, operates as a medical education group in brazil. the company provides educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. it offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil and mechanical engineering, industrial engineering, dentistry, pedagogy, nutrition, physiotherapy, psychology, architecture, veterinary medicine, and others. in addition, the company provides distance learning residency preparatory courses through its online platform; and develops and sells pr